Article Details

ProMIS Neurosciences Announces Second Quarter 2025 Financial Results & Corporate Highlights

Retrieved on: 2025-08-13 12:11:07

Tags for this article:

Click the tags to see associated articles and topics

ProMIS Neurosciences Announces Second Quarter 2025 Financial Results & Corporate Highlights. View article details on hiswai:

Excerpt

... antibodies or vaccine formulations. Application of the ProMIS platform produced PMN310, a clinical stage, humanized monoclonal antibody candidate ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo